Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Assets (2018 - 2025)

TransMedics has reported Assets over the past 8 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Assets at $1.1 billion for Q4 2025, up 32.87% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (up 32.87% YoY), and the annual figure for FY2025 was $1.1 billion, up 32.87%.
  • Assets for Q4 2025 was $1.1 billion at TransMedics, up from $946.0 million in the prior quarter.
  • Over the last five years, Assets for TMDX hit a ceiling of $1.1 billion in Q4 2025 and a floor of $117.3 million in Q2 2022.
  • Median Assets over the past 5 years was $689.8 million (2023), compared with a mean of $526.6 million.
  • Biggest five-year swings in Assets: dropped 17.68% in 2021 and later surged 488.62% in 2023.
  • TransMedics' Assets stood at $134.9 million in 2021, then surged by 105.46% to $277.1 million in 2022, then skyrocketed by 154.76% to $706.0 million in 2023, then grew by 13.88% to $804.1 million in 2024, then soared by 32.87% to $1.1 billion in 2025.
  • The last three reported values for Assets were $1.1 billion (Q4 2025), $946.0 million (Q3 2025), and $890.5 million (Q2 2025) per Business Quant data.